EGFR and glioblastoma: GBM is also characterized by EGFR amplification, particularly the EGFRvIII mutant, which is central to its aggressive growth and resistance to treatment—this is a defining feature of GBM and rarely seen in other tumors like meningiomas or low-grade astrocytomas.